55 filings
Page 2 of 3
8-K
gg4t6
19 Sep 17
Departure of Directors or Certain Officers
12:00am
8-K
zwbsfoq n6twg9u67hun
2 Aug 17
OncoMed Announces Second Quarter 2017 Financial Results
12:00am
8-K
snmkp9bwbhttxn5dh60s
10 Jul 17
Termination of a Material Definitive Agreement
12:00am
8-K
vm3ve 6f66
5 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
cjszr8
8 May 17
OncoMed Announces First Quarter 2017 Financial Results and Demcizumab DENALI Results
12:00am
8-K
rpmrfa
28 Apr 17
Cost Associated with Exit or Disposal Activities
12:00am
8-K
u2ckpz 8s2jxdyu
17 Apr 17
Results of Operations and Financial Condition
12:00am
8-K
8pw7bdtgqroh7k1ay8v9
10 Apr 17
Other Events
12:00am
8-K
zks7vl4
8 Mar 17
OncoMed Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
c3l8b4m86c8j
5 Jan 17
OncoMed Announces Year-End Cash Balance and 2017 Outlook
12:00am
8-K
ym8jk3
6 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
ul2o2ukbjuhd7j9
1 Nov 16
OncoMed Pharmaceuticals Reports Third Quarter 2016 Financial Results
12:00am
8-K
4eah9a p59b6cg
23 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
dhdaeqajqh2lzfsxbu
9 Aug 16
Second Quarter 2016 Financial Results
12:00am
8-K
072rl ajka
24 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
5x46wauhkh93sc1 klm
5 May 16
First Quarter 2016 Financial Results
12:00am
8-K
k893q8tai ay4x
10 Mar 16
Fourth Quarter 2015 Financial Results and 2016 Guidance
12:00am
8-K
ax657v15taz04iif
25 Jan 16
OncoMed Provides Update on Tarextumab Phase 2
12:00am
8-K
wtepqs3osgacpy
6 Jan 16
OncoMed Pharmaceuticals Appoints Perry Karsen to Board of Directors
12:00am
8-K
l7lc6gnp5s 8g2qxa
5 Jan 16
Announces Year-End Cash Balance
12:00am